Reductions in the primary endpoint with prasugrel versus clopidogrel ( hazard ratio -LSB- HR -RSB- : @ ; @ % confidence interval -LSB- CI -RSB- : @ to @ ; p = @ ) were consistent between primary and secondary PCI patients at @ months ( HR : @ ; @ % CI : @ to @ vs. HR : @ ; @ % CI : @ to @ ; p interaction = @ ) .